In addition, serum ALT was also normalized to the wildtype level after ABE treatment while BUN remained the same before or after ABE administration (Fig. S15b, c), suggesting the safe and therapeutic outcomes after systemic delivery of AAV-ABE in 2-week-old DMD mice. This evidence concerns the gene GPT and Duchenne muscular dystrophy.